Systematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis

The Oncologist
Zhiyu WangHui Zhao

Abstract

Complications from skeletal-related events (SREs) constitute a challenge in the care of cancer patients with bone metastasis (BM). This study evaluated the comparative effectiveness of pamidronate, ibandronate, zoledronate, and denosumab in reducing the morbidity of SREs in cancer patients with BM. Medline (1948 to January 2014), Embase (1980 to January 2014), the Cochrane Library (2014 issue 1), and Web of Science with Conference Proceedings (1970 to January 2014) were searched. Only randomized controlled trials assessing denosumab, bisphosphonates, or placebo in cancer patients with BM were included. The primary outcomes were SREs and SREs by type. The network meta-analysis (NMA) was performed with a random-effects Bayesian model. The NMA included 14 trials with 10,192 patients. Denosumab was superior to placebo in reducing the risk of SREs (odds ratio [OR]: 0.49; 95% confidence interval [CI]: 0.31-0.75), followed by zoledronate (OR: 0.57; 95% CI: 0.41-0.77) and pamidronate (OR: 0.55; 95% CI: 0.41-0.72). Ibandronate compared with placebo could not reduce the risk of SREs. Denosumab was superior to placebo in reducing the risk of pathologic fractures (OR: 0.50; 95% CI: 0.32-0.79), followed by zoledronate (OR: 0.61; 95% CI: 0.4...Continue Reading

References

Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R L TheriaultD J Reitsma
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans D MenssenPierre D Delmas
Oct 3, 2002·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·A HeidenreichR Hofmann
Sep 5, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-J BodyUNKNOWN MF 4265 Study Group
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J SmallMildred Ortu Kowalski
Feb 13, 2004·Health Technology Assessment : HTA·J R RossK Broadley
Apr 28, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D TripathyUNKNOWN MF 4434 Study Group
Jun 3, 2004·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Sep 28, 2004·Statistics in Medicine·G Lu, A E Ades
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Norio KohnoShigemitsu Takashima
Apr 13, 2005·Clinical Therapeutics·Debu TripathyBengt Bergström
Oct 15, 2005·BMJ : British Medical Journal·Deborah M CaldwellJ P T Higgins
Feb 1, 2006·PharmacoEconomics·A E AdesGuobing Lu
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-Jacques BodyPirow J Bekker
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert E Coleman
Sep 6, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allan LiptonSusie Jun
Apr 9, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Luis CostaAndrew Wardley
May 21, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeroen P JansenWiro Stam
Feb 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karim FizaziSusie Jun
Sep 23, 2009·International Journal of Clinical Practice·W L BakerUNKNOWN Health Outcomes, Policy, and Economics (HOPE) Collaborative Group
Nov 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alison T StopeckAda Braun
Feb 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H HenryHoward Yeh
Jun 29, 2011·BMC Medicine·Tianjing LiUNKNOWN Ad Hoc Network Meta-analysis Methods Meeting Working Group
Aug 22, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·John A FordGraham Mowatt
Sep 15, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Allan LiptonSusie Jun

❮ Previous
Next ❯

Citations

Feb 7, 2016·The Bone & Joint Journal·A J FarrierM Z Choudhury
Nov 27, 2015·The Lancet. Diabetes & Endocrinology·Julien HadouxMartin Schlumberger
Jul 6, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Gustavo Telles da SilvaLuiz Claudio Santos Thuler
Feb 3, 2016·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Prakirthi YerramOsama Abdelghany
Dec 7, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Prakirthi YerramSally Y Barbour
Sep 8, 2018·British Journal of Clinical Pharmacology·Michael Kriegbaum SkjødtBo Abrahamsen
Aug 10, 2020·Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews·Humaid Al FariiRobert Turcotte
Nov 20, 2016·Asia-Pacific Journal of Clinical Oncology·Kenneth PittmanRichard H de Boer
Nov 16, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Akanksha SrivastavaMark S Chambers
Mar 20, 2021·Curēus·Charumathi Raghu SubramanianBahar Moftakhar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.